Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
229.3 USD | +0.67% | +1.44% | -2.69% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.69% | 11.7B | |
+2.25% | 42.59B | |
+7.61% | 40.65B | |
+48.83% | 40.57B | |
-11.96% | 26.77B | |
+8.64% | 24.81B | |
-23.86% | 18.17B | |
+28.06% | 12.05B | |
+6.98% | 11.1B | |
-17.20% | 9.85B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Guggenheim Upgrades Charles River Laboratories International to Buy From Neutral, $255 Price Target